source
- Mimetic Medicines' peptide reduces pain-related sodium channels in mice, offering new neuropathic pain strategyResearchers at Mimetic Medicines tested a short lipidated peptide (SLiP) in mice and found it lowered the presence of Nav1.8 sodium channels on sensory neuron membranes. Reducing these channels hel…
- FDA issues request for information on early-phase ibogaine trial designThe FDA announced a request for information (RFI) to gather input on how to design early-phase clinical trials of ibogaine drug products. The agency is looking for comments on protocol elements su…